rhegmatogenous retinal detachment Clinical Trials

9 recruitingLast updated: May 11, 2026

There are 9 actively recruiting rhegmatogenous retinal detachment clinical trials across 6 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Boston, Massachusetts, United States, Birmingham, United Kingdom, Belfast, United Kingdom. Updated daily from ClinicalTrials.gov.


rhegmatogenous retinal detachment Trials at a Glance

9 actively recruiting trials for rhegmatogenous retinal detachment are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Birmingham, and Belfast. Lead sponsors running rhegmatogenous retinal detachment studies include Massachusetts Eye and Ear Infirmary, Eye & ENT Hospital of Fudan University, and Clinical Hospital Center, Split.

Browse rhegmatogenous retinal detachment trials by phase

Treatments under study

About rhegmatogenous retinal detachment Clinical Trials

Looking for clinical trials for rhegmatogenous retinal detachment? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new rhegmatogenous retinal detachment trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about rhegmatogenous retinal detachment clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Acute Retinal Detachment Repair With the iSeelr™ Retinal Detachment Repair System

Rhegmatogenous Retinal Detachment - Macula Off
Photofuse Pty Ltd10 enrolled1 locationNCT06468397
Recruiting
Phase 1Phase 2

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

rhegmatogenous retinal detachmentProliferative Vitreoretinopathy
Massachusetts Eye and Ear Infirmary48 enrolled1 locationNCT06033703
Recruiting
Not Applicable

hAM for Inferior RRD

rhegmatogenous retinal detachment
Eye & ENT Hospital of Fudan University50 enrolled1 locationNCT07081945
Recruiting
Phase 4

Dropless Pars Plana Vitrectomy Study

rhegmatogenous retinal detachment
Massachusetts Eye and Ear Infirmary168 enrolled1 locationNCT05331664
Recruiting
Phase 3

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

rhegmatogenous retinal detachment
Queen's University, Belfast276 enrolled27 locationsNCT06997874
Recruiting

Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence After Vitrectomy with Silicone Oil Tamponade in Retinal Detachment Patients

rhegmatogenous retinal detachment
First Affiliated Hospital of Chongqing Medical University65 enrolled1 locationNCT06826573
Recruiting
Phase 2

Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Unity Health Toronto50 enrolled2 locationsNCT05523869
Recruiting
Not Applicable

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

rhegmatogenous retinal detachment
Clinical Hospital Center, Split40 enrolled1 locationNCT06694259
Recruiting
Phase 2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

rhegmatogenous retinal detachmentProliferative Vitreoretinopathy
Cincinnati Eye Institute, Southwest Ohio860 enrolled1 locationNCT06541574